TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer
Go back to TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,691,379 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,691,379 | |||||
| Compugen Ltd (NASDAQ: CGEN) | Delayed: 1.94 -0.02 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.96 | 52 Week High | $7.79 | |||
| Open | $1.97 | 52 Week Low | $4.32 | |||
| Day High | $1.97 | P/E | N/A | |||
| Day Low | $1.89 | EPS | $-0.36 | |||
| Volume | 148,021 | |||||
| Compugen Ltd (NASDAQ: CGEN) | Delayed: 1.94 -0.02 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.96 | 52 Week High | $7.79 | |||
| Open | $1.97 | 52 Week Low | $4.32 | |||
| Day High | $1.97 | P/E | N/A | |||
| Day Low | $1.89 | EPS | $-0.36 | |||
| Volume | 148,021 | |||||
| Daiichi Sankyo Co Limited Sponsored ADR (AMEX: DSNKY) | Delayed: 17.84 -0.27 (1.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.11 | 52 Week High | $26.24 | |||
| Open | $18.08 | 52 Week Low | $18.86 | |||
| Day High | $18.08 | P/E | N/A | |||
| Day Low | $17.77 | EPS | $0.00 | |||
| Volume | 72,844 | |||||



